Forward Features Calendar

Intel

CVS adds four to Board in deal with activist Glenview

CVS Health is adding four new members to its board of directors, including Larry Robbins, CEO of Glenview Capital Management—the hedge fund firm which has been pushing for changes at the healthcare giant after acquiring a significant stake in the

Digital assets funds YTD inflows break $33.5bn

Digital asset inflows reached $2.2bn last week, bringing year-to-date inflows to a record-breaking $33.5bn, according to the latest Digital Assets Fund Flows Weekly Report from CoinShares.

Tiger-related funds make bold bets in Q3

Several prominent hedge funds with ties to the Tiger Management legacy, including Discovery Capital Management, made significant new investments during the third quarter, according to a report by Institutional Investor citing analysis of their recently filed 13F regulatory disclosures.

Archegos founder Hwang should serve 21-years, say US prosecutors

Bill Hwang, founder of Archegos Capital Management, should serve 21 years in prison for orchestrating a market manipulation scheme that collapsed his $36bn fund and inflicted more than $10bn in losses on lenders, according to a report by Reuters citing

Arcesium unveils new regulatory reporting solution

Arcesium, a provider of investment lifecycle and data management technology for the global investment industry, has launched a new automated Regulatory Reporting solution aimed at reducing the resources required to manage regulatory compliance.

Activist hedge fund ValueAct adds $121m to Meta bet

Activist hedge fund ValueAct Holdings has significantly increased its stake in Meta Platforms, acquiring 211,500 additional shares, worth $121.07m, during the third quarter of 2024, according to the firm’s latest 13F filing.

Events

08 October, 2026 – 5:00 pm

Directory Listings

Please select one of the below *
Notify Me
Firm Type *
Please select below
Terms & Conditions *
Privacy Policy *